LAVA Therapeutics N.V. financial statements, including revenue, expenses, profit, and loss

The total revenue of LVTX for the last quarter is 353.00 k USD, and it's 566.04% higher compared to the previous quarter. The net income of Q4 23 is -6.50 M USD.